GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 114 filers reported holding GOSSAMER BIO INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $117,224 | -100.0% | 54,020 | +12.7% | 0.00% | – |
| Q3 2022 | $574,453,000 | +43.1% | 47,951 | 0.0% | 0.00% | – |
| Q2 2022 | $401,349,000 | -3.6% | 47,951 | 0.0% | 0.00% | – |
| Q1 2022 | $416,214,000 | -23.3% | 47,951 | 0.0% | 0.00% | – |
| Q4 2021 | $542,326,000 | -13.3% | 47,951 | -3.6% | 0.00% | – |
| Q3 2021 | $625,257,000 | +54.8% | 49,742 | 0.0% | 0.00% | – |
| Q2 2021 | $403,906,000 | -20.1% | 49,742 | -9.0% | 0.00% | – |
| Q1 2021 | $505,532,000 | +23.1% | 54,652 | +28.7% | 0.00% | – |
| Q4 2020 | $410,511,000 | -33.8% | 42,452 | -15.0% | 0.00% | – |
| Q3 2020 | $619,904,000 | +10.8% | 49,952 | +16.0% | 0.00% | – |
| Q2 2020 | $559,676,000 | +392.3% | 43,052 | +284.4% | 0.00% | – |
| Q1 2020 | $113,680,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,758,069 | $23,085,000 | 6.16% |
| Ally Bridge Group (NY) LLC | 700,000 | $5,859,000 | 5.34% |
| Kynam Capital Management, LP | 2,350,448 | $19,673,000 | 5.02% |
| Omega Fund Management, LLC | 1,500,000 | $12,555,000 | 4.01% |
| Ikarian Capital, LLC | 1,000,387 | $8,373,000 | 1.53% |
| HHLR ADVISORS, LTD. | 7,420,974 | $62,114,000 | 1.33% |
| Boxer Capital, LLC | 2,462,358 | $20,610,000 | 1.30% |
| Palo Alto Investors LP | 1,750,651 | $14,653,000 | 1.28% |
| Artal Group S.A. | 2,358,968 | $19,745,000 | 1.06% |
| Birchview Capital, LP | 159,088 | $1,332,000 | 0.97% |